EditorialsNorth American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19Bergsland, Emily K. MD∗; Halperin, Daniel M. MD†; Dillon, Joseph S. MD‡; Dasari, N. Arvind MD§; Kunz, Pamela L. MD∥; Soares, Heloisa P. MD, PhD¶; Pryma, Daniel MD#; Bodei, Lisa MD, PhD∗∗; Hope, Thomas MD††; Soulen, Michael C. MD#; Mailman, Josh MBA‡‡; Howe, James R. MD§§Author Information From the ∗Department of Medicine, University of California San Francisco, San Francisco, CA †Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Medicine, University of Iowa Carver College of Medicine, Iowa City, IA §Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX ∥Department of Medicine, Stanford University Medical Center, Palo Alto, CA ¶Department of Medicine, University of Utah Health, Salt Lake City, UT #Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA ∗∗Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY ††Department of Radiology, University of California San Francisco, San Francisco ‡‡NorCal CarciNET Community, Ripon, CA §§Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA. Address correspondence to: James R. Howe, MD, Department of Surgery, University of Iowa Hospitals and Clinics, 4644, JCP, 200 Hawkins Drive, Iowa City, IA 52242 (e-mail: firstname.lastname@example.org). The authors declare no conflict of interest. Disclaimer: COVID-19 is an unprecedented, evolving public health emergency. The purpose of this document is to provide neuroendocrine tumor medical professionals with information specific for neuroendocrine tumor/neuroendocrine carcinoma patients incorporating the advice of multiple societies. Given the rapidly changing nature of this public health emergency, new or different information will continue to emerge after the posting of this document. The North American Neuroendocrine Tumor Society strives to maintain updated information on its website, www.nanets.net. However, the North American Neuroendocrine Tumor Society assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions. Pancreas: July 2020 - Volume 49 - Issue 6 - p 723-728 doi: 10.1097/MPA.0000000000001561 Buy Metrics Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.